Prosthetic Joint Infection Clinical Trial
Official title:
Treating the Whole Patient: Measuring Distress in Prosthetic Joint Infection Using a Standardized Metric: CRUTCH Pathway Pilot.
NCT number | NCT04762706 |
Other study ID # | 2101221058 |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | March 4, 2021 |
Est. completion date | May 2024 |
The purpose of this study is to determine whether patients being treated for prosthetic joint infections (PJI) experience distress during the course of their treatment and how distress influences various aspects of their lives. WVU expects to enroll approximately 12 subjects. Patients identified as scoring ≥4 on the Distress Thermometer at the two-week follow-up visit will be offered the opportunity to participate in the novel CRUTCH Pathway. Once enrolled, you will meet virtually with a mental health provider. The mental health provider will complete a 30-minute intake visit where he will review your distress thermometer scoring, discuss contributing factors to current distress level, and assess for psychiatric comorbidities.
Status | Recruiting |
Enrollment | 12 |
Est. completion date | May 2024 |
Est. primary completion date | January 1, 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 89 Years |
Eligibility | Inclusion Criteria: - ability to speak and read English, and cognitively sound. Patients scheduled for revision of total hip or knee arthroplasty will be categorized as septic or aseptic revisions. Patients identified as scoring =4 on the DT at the two-week follow-up visit. Exclusion Criteria: - Patients younger than 18 or older than 89, patients unable to speak and/or read English, and patients who are not able to understand and answer questions asked on surveys. Elective primary total hip or knee arthroplasty, hemiarthroplasty, unicompartmental knee arthroplasty. |
Country | Name | City | State |
---|---|---|---|
United States | WVU Medicine University Town Center | Morgantown | West Virginia |
Lead Sponsor | Collaborator |
---|---|
West Virginia University |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Assess patient experience with a Distress Thermometer and Problem List | Distress Thermometer and Problem List for Patients with a score from 0-10, where 0 is no distress and 10 extreme distress. | Two week post operative |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04067843 -
Effect of Photodynamic Treatment on Skin Microbiome. Single Center Study
|
N/A | |
Enrolling by invitation |
NCT05247281 -
NGS vs Culture Outcomes for Treatment of PJI
|
N/A | |
Withdrawn |
NCT05269121 -
Bacteriophage Therapy in First Time Chronic Prosthetic Joint Infections
|
Phase 1/Phase 2 | |
Recruiting |
NCT02801253 -
Cohort of Prosthetic Joint Infections
|
||
Completed |
NCT03694925 -
Diagnostic Utility of a Novel Point-of-Care Test of Calprotectin for Revision Total Knee Arthroplasty
|
||
Completed |
NCT03721328 -
Safety and Efficacy in Patients Treated for Hip or Knee PJI With Vancomycin and Tobramycin Joint Irrigation
|
Phase 2 | |
Withdrawn |
NCT04787250 -
Bacteriophage Therapy in Patients With Prosthetic Joint Infections
|
Phase 1/Phase 2 | |
Recruiting |
NCT03307109 -
Quality of Life in Patients Having a Prosthetic Joint Infection
|
||
Recruiting |
NCT04661345 -
Identification of Molecular Marker of Coagulase-negative Staphylococci for the Diagnosis of Prosthetic Joint Infections
|
||
Recruiting |
NCT02805803 -
Quality of Life Assessment in Patients Undergoing Prolonged Suppressive Antibiotherapy for Prosthetic Joint Infection.
|
N/A | |
Completed |
NCT02413034 -
The Influence of Antibiotic Prophylaxis on Intraoperative Prosthetic Joint Infection Cultures
|
N/A | |
Recruiting |
NCT03784807 -
New Strategies for Biofilm Related Infections
|
||
Completed |
NCT04662632 -
Abbreviated Protocol for Two-Stage Exchange
|
Phase 2 | |
Not yet recruiting |
NCT04390607 -
Leukocyte Esterase Sensor Test
|
||
Recruiting |
NCT04650607 -
Phage Safety Cohort Study
|
||
Active, not recruiting |
NCT04946500 -
Clindamycin in Prosthetic Joint Infections Caused by Staphylococcus (CISTA)
|
||
Withdrawn |
NCT05269134 -
Bacteriophage Therapy in Patients With Prosthetic Joint Infections (PJI)
|
Phase 2 | |
Not yet recruiting |
NCT05239312 -
Antibiogram and Biofilm Formation of Bacteria Causing Prosthetic Joint Infections Isolated From Assiut University Hospital
|
||
Completed |
NCT04294862 -
Tissue Distribution, Pharmacokinetics, Safety, and Tolerability After a Single Dose of TNP-2092 in Participants Undergoing Primary Total Hip or Knee Arthroplasty
|
Phase 1 | |
Recruiting |
NCT05060952 -
Calprotectin in Chronic Prosthetic Joint Infection
|